JAMA Medical News

JAMA Associate Editor John M. Inadomi, MD, discusses clinical highlights from United European Gastroenterology (UEG) Week with UEG president Helena Cortez-Pinto, MD, PhD.

Related Content:

• Highlights From Gastroenterology Week: New Crohn Disease Drug, Redefining Liver Disease, and More

AI has potential to meaningfully improve patient care. How will AI advances help clinicians focus on the best use of their time and talents? In this Q&A, JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, interviews Suchi Saria, PhD, MSc, an associate professor in computer science at Johns Hopkins, to discuss how AI could streamline care.

Related Content:

• Can Predictive AI Improve Early Detection of Sepsis and Other Conditions?

Who Should Get the New Alzheimer Disease Drug? Could Universal Donor Blood Be Made in the Lab? More Than 1 in 4 Nurses Say They Plan to Leave Health Care

Related Content:

• Who Should—and Can—Get Lecanemab, the New Alzheimer Disease Drug?
• Could Universal Donor Blood Be Made in the Laboratory?
• Overworked and Understaffed, More Than 1 in 4 US Nurses Say They Plan to Leave the Profession

In this Q&A, JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, and Bernard S. Chang, MD, MMSc, a neurologist and dean for medical education at Harvard Medical School, discuss how AI will change medical education, admissions, and teaching the future generation of physicians and clinicians.

Related Content:

• AI Will—and Should—Change Medical School, Says Harvard’s Dean for Medical Education
• Transformation of Undergraduate Medical Education in 2023

In this Q&A, JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, talks with Andrew Bindman, MD, an internist and the executive vice president and chief medical officer for Kaiser Permanente, about AI implementation and the importance of building trust in a health care system.

Related Content:

• Kaiser Permanente’s CMO: How AI Might Help Clinicians Address Patients’ Social Risk Factors

In this Q&A, JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, interviews Kedar S. Mate, MD, an internal medicine physician, President and Chief Executive Officer at the Institute for Healthcare Improvement, and faculty at Weill Cornell Medical College, to discuss AI’s role in health care quality and approaches to improving health equity.

Related Content:

• New AI Tools Must Have Health Equity in Their DNA

In this Q&A, JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, and Kevin B. Johnson, MD, MS, the David L. Cohen and Penn Integrates Knowledge University Professor of Pediatrics, Informatics, Engineering, and Communication at the University of Pennsylvania, discuss how AI can reduce clinician burden and streamline health system functions.

Related Content:

• Electronic Health Records Failed to Make Clinicians’ Lives Easier—Will AI Technology Succeed?

Should Consumers Buy a Blood Test to Evaluate Their Alzheimer Disease Risk; How Wildfire Smoke Harms Health

Related Content:

• Consumers Can Now Buy a Blood Test to Evaluate Their Alzheimer Disease Risk, but Should They?
• Raging Wildfires Are Exposing More People to Smoky Air—Here’s What That Means for Health

In this Q&A, JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, and Ida Sim, MD, PhD, a primary care physician and UCSF’s Chief Research Informatics Officer, discuss generative AI, large language models, and the ways in which AI could affect humanity in medicine.

Related Content:

• The Promise and Pitfalls of AI in the Complex World of Diagnosis, Treatment, and Disease Management

In this Q&A, JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, interviews Michael Howell, MD, MPH, a pulmonologist and chief clinical officer at Google, to discuss the evolution of AI and what we should expect next for AI and health care.

Related Content:

• Google Health’s Chief Clinical Officer Talks About Incorporating AI in Health Care